Sign in to continue:

Tuesday, March 17th, 2026

ASTI Holdings Receives SGX Approval-in-Principle for S$0.025 Placement of Up to 128 Million New Shares




ASTI Holdings Limited Receives Approval-in-Principle for S\$3.2 Million Share Placement

ASTI Holdings Limited Receives SGX Approval-in-Principle for Major Share Placement

Key Highlights

  • Proposed Placement: Up to 128,000,000 new ordinary shares to be issued at S\$0.025 per share.
  • Potential Capital Raised: If fully subscribed, the placement would raise up to S\$3.2 million for the company.
  • SGX-ST Approval-in-Principle: The Singapore Exchange Securities Trading Limited (SGX-ST) granted approval-in-principle (AIP) for the listing and quotation of these shares on 15 January 2026.
  • Placement Deadline: Shares must be placed out within 7 market days from the AIP date.
  • Stringent Compliance Requirements: Multiple undertakings and confirmations are required to ensure compliance with SGX Listing Manual rules.

Details of the Share Placement

ASTI Holdings Limited announced the proposed placement of up to 128 million new ordinary shares at an issue price of S\$0.025 per share. This move, first referenced in the company’s 9 January 2026 announcement, represents a significant capital-raising exercise designed to strengthen ASTI’s balance sheet and provide additional working capital. At the placement price, the total funds that could be raised amount to S\$3.2 million.

The company received the crucial approval-in-principle from the SGX-ST on 15 January 2026. This approval is a key regulatory milestone and is required before the new shares can be listed and traded on the SGX. Importantly, the AIP is not an endorsement of the merits of the placement, shares, or company by the SGX.

Key Conditions and Compliance Undertakings

The approval is subject to several critical conditions:

  • Use of Proceeds Disclosure: ASTI must provide a written undertaking to comply with SGX Listing Manual Rules 704(30) and 1207(20). This requires clear disclosure on the use of placement proceeds, especially if used for working capital, with detailed breakdowns in company announcements and the annual report.
  • Public Float Requirement: The company and the placement agent must undertake to comply with Rule 803, ensuring adequate public float of shares post-placement.
  • Restrictions on Allottees: Both ASTI and the placement agent must confirm in writing that the placement shares will not be issued to or placed with persons prohibited under Rule 812(1), which includes directors, substantial shareholders, and other restricted parties.

These measures are intended to promote transparency and safeguard shareholder interests.

The placement shares must be subscribed for and placed out within 7 market days from the date of the AIP, meaning this capital-raising exercise will move swiftly to completion.

Implications for Shareholders and Share Price

This announcement is highly significant for ASTI shareholders and potentially price-sensitive:

  • Dilution Risk: The issuance of up to 128 million new shares may dilute existing shareholders’ equity and earnings per share, a factor investors should consider when evaluating their positions.
  • Capital Injection: The S\$3.2 million to be raised could enhance ASTI’s liquidity, support business operations, or fund strategic initiatives—potentially strengthening the company’s financial position and future growth prospects.
  • Market Sentiment: The placement price of S\$0.025 per share may serve as a reference point for the stock’s short-term valuation, possibly influencing market trading activity. The prompt execution timeline (within 7 market days) adds to the immediacy of potential market impact.
  • Regulatory Compliance: The company’s strict adherence to SGX rules and requirements is reassuring for investors concerned about governance and transparency.

Next Steps

ASTI Holdings will provide further updates as developments occur, particularly regarding the completion of the placement and the use of proceeds.

Conclusion

The successful placement and the resulting infusion of capital could be transformative for ASTI Holdings, supporting its operational and strategic goals. However, investors should also be aware of the dilution implications and monitor management’s deployment of the funds. This is a material development that could affect the company’s share price in the near term.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence or consult with a qualified financial advisor before making any investment decisions. The author and publisher are not liable for any losses arising from reliance on this information.




View ASTI Historical chart here



SDAI Limited Announces Joint Venture with Hubei Qiai to Expand Moxibustion Products in ASEAN Region

SDAI Limited Forms Joint Venture with Hubei Qiai Group to Ex...

   Ad